ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18300; 2) Community: the network communities that were significantly associated with the response to NSC 18300; 3) Molecule: the relationships between components within communities and NSC 18300; 4) MDR: the compounds that were significantly associated with the NSC 18300.

NSC Compound Enrichment Correlation
NSC 735403 Null 0.0291420747327558 0.29791289
NSC 76150 Null 0.0291420747327558 0.59051706
NSC 95466 PCNU 0.0291420747327558 0.20548178
NSC 104801 Cytembena 0.029142074732756 0.25224773
NSC 107043 Null 0.029142074732756 0.24563752
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.029142074732756 -0.18976501
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.029142074732756 0.41535108
NSC 176323 Camptothecin Derivative 0.029142074732756 0.16963907
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0321614375606958 0.40163919
NSC 629595 Null 0.0321614375606958 0.4555798
Total:82  Current:52    [First] [Prev] [Next] [Last]